Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

[Urinary level of tissue factor and its procoagulant activity in patients with type 2 diabetes].

Fu WJ, Zheng L, Wang Q, Deng RT, Ye CQ, Wang SB, Peng LF, Xiong SL, Tang HH.

Nan Fang Yi Ke Da Xue Xue Bao. 2011 May;31(5):878-81. Chinese.

2.

Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.

Wang QY, Chen FQ.

Diabetes Res Clin Pract. 2009 Feb;83(2):215-9. doi: 10.1016/j.diabres.2008.09.048. Epub 2008 Dec 20.

PMID:
19097668
3.

Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy.

Tashiro K, Koyanagi I, Ohara I, Ito T, Saitoh A, Horikoshi S, Tomino Y.

J Clin Lab Anal. 2004;18(3):206-10.

PMID:
15103687
4.

[Change and significance of urinary smad3 in type 2 diabetic nephropathy].

Guo KF, Kou JX, Lu JX, Zhang L, Yu HY, Chen HB.

Zhonghua Yi Xue Za Zhi. 2013 Apr 9;93(14):1067-71. Chinese.

PMID:
23902838
6.

[Change and significance of serum pigment epithelium-derived factor in type 2 diabetic nephropathy].

Chen HB, Jia WP, Lu JX, Bao YQ, Li Q, Lu FD, Lu W, Yu HY, Xiang KS.

Zhonghua Yi Xue Za Zhi. 2007 May 15;87(18):1230-3. Chinese.

PMID:
17686253
7.

Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.

Navarro JF, Mora C, Muros M, García J.

Nephrol Dial Transplant. 2006 Dec;21(12):3428-34. Epub 2006 Aug 25.

PMID:
16935891
8.

Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.

Awadallah SM, Saleh SA, Abu Shaqra QM, Hilow H.

J Diabetes Complications. 2008 Nov-Dec;22(6):384-8. doi: 10.1016/j.jdiacomp.2007.07.004. Epub 2008 Apr 16.

PMID:
18413152
9.

Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus.

Mojahedi MJ, Bonakdaran S, Hami M, Sheikhian MR, Shakeri MT, Aiatollahi H.

Iran J Kidney Dis. 2009 Jan;3(1):12-6.

10.

Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.

Kazumi T, Hozumi T, Ishida Y, Ikeda Y, Kishi K, Hayakawa M, Yoshino G.

Diabetes Care. 1999 Jul;22(7):1176-80.

11.

Practical aspects of measuring microalbuminuria in diabetic patients.

Jermendy G, Farkas K, Nádas J, Daróczy A, Péterfai E.

Diabetes Nutr Metab. 2001 Aug;14(4):195-200.

PMID:
11716288
12.
13.

The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy.

Zelmanovitz T, Gross JL, Oliveira JR, Paggi A, Tatsch M, Azevedo MJ.

Diabetes Care. 1997 Apr;20(4):516-9.

PMID:
9096972
14.

Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.

Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H.

Diabetes Care. 2005 Nov;28(11):2728-32.

PMID:
16249547
15.

Effect of glycemic control on microalbuminuria development among type 2 diabetes with high-normal albuminuria.

Chen WZ, Hung CC, Wen YW, Ning HC, Gau BR, Huang YY.

Ren Fail. 2014 Mar;36(2):171-5. doi: 10.3109/0886022X.2013.832312. Epub 2013 Sep 13.

PMID:
24028605
16.

Serum and urinary nitric oxide in Type 2 diabetes with or without microalbuminuria: relation to glomerular hyperfiltration.

Apakkan Aksun S, Ozmen B, Ozmen D, Parildar Z, Senol B, Habif S, Mutaf I, Turgan N, Bayindir O.

J Diabetes Complications. 2003 Nov-Dec;17(6):343-8.

PMID:
14583179
17.

Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial.

Petrica L, Petrica M, Vlad A, Dragos Jianu C, Gluhovschi G, Ianculescu C, Dumitrascu V, Giju S, Gluhovschi C, Bob F, Ursoniu S, Gadalean F, Velciov S, Bozdog G, Marian R.

Wien Klin Wochenschr. 2009;121(23-24):765-75. doi: 10.1007/s00508-009-1279-3.

PMID:
20047115
18.
19.
20.

Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus.

Navarro JF, Mora C, Maca M, Garca J.

Am J Kidney Dis. 2003 Jul;42(1):53-61.

PMID:
12830456

Supplemental Content

Support Center